Ezell Askew, MD
Interventional Pain Medicine · Lodi, CANPI 1699760769
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $60,304 of the $86,564 with a category attached, or 69.7%. 32 manufacturers reported payments, led by Flowonix Medical Incorporated at 43.6% of the total. Reporting peaked in 2019 at $44,302 and has fallen 85.5% since, to $6,402 in 2025. Among interventional pain medicine clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 366 payments — averaging $236.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Flowonix Medical Incorporated$38K
- Nevro Corp.$28K
- Medtronic$8K
- Globus Medical$4K
- Philips North America LLC$3K
- Boston Scientific$2K
- plus $5K from 26 others
Across 1 payment — averaging $2500.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Globus Medical$3K
What the payments were for
- Consulting fees$60,30470%
- Speaking & faculty fees$11,01313%
- Travel & lodging$7,0178%
- Food & beverage$8,23010%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Flowonix Medical Incorporated | 1 | $37,700 |
| Nevro Corp. | 40 | $27,863 |
| Medtronic(2 entities) | 101 | $7,631 |
| Globus Medical | 20 | $3,907 |
| Philips North America LLC | 26 | $3,339 |
| Boston Scientific | 72 | $1,561 |
| Relievant Medsystems, Inc. | 30 | $1,098 |
| Bard Peripheral Vascular, Inc. | 15 | $976 |
| Surgentec | 1 | $745 |
| Stryker | 5 | $292 |
| Bioventus LLC | 9 | $256 |
| Si-bone, Inc. | 5 | $169 |
| Vertiflex, Inc. | 5 | $132 |
| Biotissue Holdings Inc. | 7 | $123 |
| Shockwave Medical, Inc | 4 | $113 |
| Penumbra, Inc. | 2 | $106 |
| Spinal Simplicity, LLC | 3 | $69 |
| Z-medica, LLC | 1 | $66 |
| Painteq LLC | 1 | $66 |
| Foundation Fusion Solutions, LLC | 2 | $52 |
| Johnson & Johnson | 3 | $48 |
| Biogen | 2 | $42 |
| Angiodynamics, Inc. | 2 | $41 |
| Catheter Precision, Inc. FKA Ra Medical Systems, Inc. | 1 | $30 |
| BD | 1 | $27 |
| Curonix LLC | 1 | $21 |
| Averitas Pharma Inc. | 1 | $17 |
| Abbott | 1 | $17 |
| Piramal Critical Care | 1 | $16 |
| Avanos Medical | 1 | $15 |
| Terumo Medical Corporation | 1 | $12 |
| Cardiovascular Systems Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Prometra II$37,700
- Vyrsa V1$27,409
- IN.PACT Admiral$3,439
- Senza$3,405
- Intracept$1,584
- HawkOne$1,326
- Spectranetics Undiv$1,200
- SYNCHROMEDII$1,102
- 3D GraftRasp System$745
- IGT D Peripheral$709
- (9520) IGT Devices Undivided$600
- Crosser iQ$454
- IVUS Systems$151
- IVS - MULTIGEN RF$150
- IVS - IVAS$150
- LUTONIX$138
- (4066) Tack Endo Sys ATK$122
- GENERAL PAIN MANAGEMENT$109
How this compares
$86,564 in reported general payments places this provider in the 90th percentile of 188 interventional pain medicine providers in California.
See all interventional pain medicine providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tizanidine Hcl | 56 | $230 |
| ClopidogrelClopidogrel Bisulfate | 16 | $43 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Lodi
- Michael Verdolinla Mesa$507K
- Tim LeierRancho Mirage$449K
- Jonathan GrossmanVisalia$404K
- Kasra MaasumiRancho Santa Margarita$388K
- Andrew GermanovichRancho Mirage$333K
- David LeeYorba Linda$257K
- Standiford HelmOrange$254K
- Patrick BuchananCamarillo$219K
- Chau VuSanta Rosa$141K
- Phillip LimBuena Park$127K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.